Mark Matza

1.8k total citations
12 papers, 147 citations indexed

About

Mark Matza is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Mark Matza has authored 12 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 3 papers in Genetics. Recurrent topics in Mark Matza's work include Vasculitis and related conditions (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Mark Matza is often cited by papers focused on Vasculitis and related conditions (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Mark Matza collaborates with scholars based in United States, Canada and Germany. Mark Matza's co-authors include John H. Stone, Ana D. Fernandes, Sebastian Unizony, Cory A. Perugino, Zachary S. Wallace, Amita Sharma, Vikram Deshpande, Hang Liu, Hugues Allard‐Chamard and Shalini Mohan and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of the Rheumatic Diseases and Seminars in Arthritis and Rheumatism.

In The Last Decade

Mark Matza

10 papers receiving 145 citations

Peers

Mark Matza

RHEUM

PRM

GENET

SURGE

EPIDE

William P. Docken United States

Fabian Arndt Germany

Delphine Larivière France

Giulia Corte Germany

Paivi Miettunen Canada

M. Santos-Gόmez Spain

Federica Bello Italy

L. Frumholtz France

Rok Ješe Slovenia

N. Le Gouellec France

William P. Docken United States

Mark Matza

154 ×1.3

RHEUM

117 ×1.4

PRM

20 ×0.5

GENET

46 ×1.4

SURGE

12 ×0.4

EPIDE

Citations per year, relative to Mark Matza Mark Matza (= 1×) peers William P. Docken

Countries citing papers authored by Mark Matza

Since Specialization

Citations

This map shows the geographic impact of Mark Matza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Matza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Matza more than expected).

Fields of papers citing papers by Mark Matza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Matza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Matza. The network helps show where Mark Matza may publish in the future.

Co-authorship network of co-authors of Mark Matza

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Matza. A scholar is included among the top collaborators of Mark Matza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Matza. Mark Matza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Tawakol, Ahmed, Brittany Weber, Michael T. Osborne, et al.. (2024). Current and Emerging Approaches to Imaging Large Vessel Vasculitis. Circulation Cardiovascular Imaging. 17(11). e015982–e015982.

2.

Nasrallah, Mazen, Sara Schoenfeld, Mark Matza, et al.. (2024). Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis. Seminars in Arthritis and Rheumatism. 69. 152573–152573. 1 indexed citations

3.

Matza, Mark, et al.. (2024). Imaging Challenges and Developments in Large-vessel Vasculitis. Rheumatic Disease Clinics of North America. 50(4). 603–621.

4.

Matza, Mark, Nicholas Dagincourt, Shalini Mohan, et al.. (2023). Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. RMD Open. 9(2). e002923–e002923. 14 indexed citations

5.

Unizony, Sebastian, et al.. (2023). Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study. The Lancet Rheumatology. 5(12). e736–e742. 18 indexed citations

6.

Hernández, Patricia, et al.. (2023). Temporal Artery Ultrasound for the Diagnosis of Giant Cell Arteritis in the Emergency Department. Cureus. 15(7). e42350–e42350. 2 indexed citations

7.

Unizony, Sebastian, et al.. (2022). OP0185 TOCILIZUMAB IN COMBINATION WITH 8 WEEKS OF PREDNISONE FOR GIANT CELL ARTERITIS. Annals of the Rheumatic Diseases. 81. 123–123. 3 indexed citations

8.

Matza, Mark, Cory A. Perugino, Liam Harvey, et al.. (2021). Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study. The Lancet Rheumatology. 4(2). e105–e112. 21 indexed citations

9.

Phadke, Neelam A., Anna R. Wolfson, Mark Matza, et al.. (2020). Electronic Consultations in Inpatient Allergy/Immunology. Journal of Allergy and Clinical Immunology. 145(2). AB345–AB345. 2 indexed citations

10.

Matza, Mark, Ana D. Fernandes, John H. Stone, & Sebastian Unizony. (2020). Ustekinumab for the Treatment of Giant Cell Arteritis. Arthritis Care & Research. 73(6). 893–897. 52 indexed citations

11.

Yokose, Chio, April Jorge, Kristin M. D’Silva, et al.. (2020). Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study. Seminars in Arthritis and Rheumatism. 50(6). 1382–1386. 8 indexed citations

12.

Wallace, Zachary S., Cory A. Perugino, Mark Matza, et al.. (2019). Immunoglobulin G4–related Disease. Clinics in Chest Medicine. 40(3). 583–597. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact